Cargando…

Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Liu, Bing, Ma, Xiaolu, Liu, Qianqian, Xiao, Yang, Pan, Shimeng, Jia, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015917/
https://www.ncbi.nlm.nih.gov/pubmed/32051397
http://dx.doi.org/10.1038/s41419-020-2320-8
_version_ 1783496880206905344
author Liu, Bing
Ma, Xiaolu
Liu, Qianqian
Xiao, Yang
Pan, Shimeng
Jia, Li
author_facet Liu, Bing
Ma, Xiaolu
Liu, Qianqian
Xiao, Yang
Pan, Shimeng
Jia, Li
author_sort Liu, Bing
collection PubMed
description
format Online
Article
Text
id pubmed-7015917
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70159172020-02-20 Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia Liu, Bing Ma, Xiaolu Liu, Qianqian Xiao, Yang Pan, Shimeng Jia, Li Cell Death Dis Retraction Note Nature Publishing Group UK 2020-02-12 /pmc/articles/PMC7015917/ /pubmed/32051397 http://dx.doi.org/10.1038/s41419-020-2320-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Retraction Note
Liu, Bing
Ma, Xiaolu
Liu, Qianqian
Xiao, Yang
Pan, Shimeng
Jia, Li
Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title_full Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title_fullStr Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title_full_unstemmed Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title_short Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
title_sort retraction note: aberrant mannosylation profile and ftx/mir-342/alg3-axis contribute to development of drug resistance in acute myeloid leukemia
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015917/
https://www.ncbi.nlm.nih.gov/pubmed/32051397
http://dx.doi.org/10.1038/s41419-020-2320-8
work_keys_str_mv AT liubing retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia
AT maxiaolu retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia
AT liuqianqian retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia
AT xiaoyang retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia
AT panshimeng retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia
AT jiali retractionnoteaberrantmannosylationprofileandftxmir342alg3axiscontributetodevelopmentofdrugresistanceinacutemyeloidleukemia